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ABSTRACT
OBJECTIVE
The objective of this selective EBM review is to determine whether the Chinese herbal
supplement, Ningdong granule, is a safe and effective alternative to haloperidol for the treatment
of tic symptoms in pediatric patients with Tourette Syndrome.
STUDY DESIGN
Systematic review of three randomized controlled trials published in 2009, 2010, and 2012.
DATA SOURCES
Three randomized controlled trials were obtained using PubMed.
OUTCOMES MEASURED
Efficacy of Ningdong granule (NDG) as compared to control groups based on decrease in tic
severity and frequency as reported by Yale Global Tic Severity Scale as well as safety, as
evidenced by prevalence of adverse drug reactions (ADRs) as compared to control groups.
RESULTS
Li et al. (2009), Wang et al. (2012), and Zhao et al. (2010) all demonstrated improvement in a
majority of the subjects’ tic symptoms while decreasing ADR’s from treatment with Ningdong
granule compared to haloperidol.
CONCLUSION
Evidence to support the efficacy of Ningdong granule to safely treat tic symptoms in pediatric
Tourette Syndrome patients is strong now, due to a relevant subject population, and consistent
standard of measurement. The data strongly supports the efficacy of Ningdong granule as an
alternative method of treating tic symptoms in pediatric patients suffering from Tourette
Syndrome.
KEY WORDS
Tourette and alternative therapy and Ningdong
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INTRODUCTION

Tourette Syndrome is a neuromuscular disorder, onset early in childhood, that causes
uncontrolled vocal and motor tics ranging from mild to severe.1,2,3,4 While the exact number of
children with Tourette Syndrome is unknown, a CDC study has shown that it affects up to 1 in
every 360 children.4 DSM diagnosis requires two motor tics and at least one vocal tic feature
occurring for at least a year, prior to age 18 that cannot be attributed to some other medical
condition or medical treatment; the diagnosis is made at an average age of 7.4 The disorder often
lasts into early adulthood (5-18 years old) and often attenuates by the time the child reaches
adulthood.4 The exact etiology of Gilles de la Tourette Syndrome (TS) is unknown, however it is
believed that there are multiple complex genetic, environmental and developmental factors that
all contribute to the frequency and severity of tic symptoms in patients.4,5 Symptoms in patients
can be socially, educationally and interpersonally impairing, thus leading to treatment for comorbid conditions as well.3 However, in some patients tics can be life threatening, as in
malignant Tourette Syndrome, or can last throughout their lives.1 This systematic review
attempts to determine whether or not the Chinese herbal supplement, Ningdong granule (NDG),
is a safe and effective alternative to haloperidol for treating tic symptoms in pediatric patients.
This paper evaluates three randomized control trials (RCT), taking place in China, comparing
Ningdong granule versus haloperidol, Ningdong granule with haloperidol, and placebo alone.

In the United States, no solid answer as to how many children or adolescents are affected,
nor how many healthcare dollars are spent on TS because in many cases there are co-morbid
obsessive compulsive or ADHD diagnoses that are more often treated and insurance billed for.5
While the CDC estimates 1 in 360 children have TS, it is also thought the actual prevalence may
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be twice that based on other studies.5 For cost, TS has been lumped into the $267 billion in
annual mental health costs for mental disorders in children. 5 Also, there is no one treatment to
track for TS as there are multiple medications used, as well as behavioral interventions like
Cognitive Behavioral Intervention for Tic therapy (CBIT). The exact number of office visits for
TS is ambiguous for the same reasons.

While the exact cause of TS is not known, it seems to have a strong genetic link affecting
mainly non-Hispanic white males with various biological, mental and environmental factors
being identified as risk factors.4 86% of Tourette Syndrome diagnoses include a comorbid
diagnosis of obsessive compulsive disorder (OCD) or attention defecit hyperactivity disorder
(ADHD).6 The gene link appears to be dominant with 50% of offspring exhibiting the trait and
males in general are 3 times more likely to exhibit symptoms of TS than females.6

It appears that the attenuation of dopamine receptors calms tic symptoms and therefore,
conventionally, traditional antipsychotic medications that work on DA such as haloperidol are
used in the management of symptoms in Tourette Syndrome. 7 It is known that these medications
can cause sometimes severe side effects such as extra pyramidal symptoms, akathisia, QT
prolongation, sedation and weight gain; for these reasons patients often discontinue their
use.1,2,3,7 Newer methods of treatment include habit reversal therapy, CBIT, psychotherapy,
acupuncture and herbal medicine.1,2,3
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OBJECTIVE

The objective of this selective EBM review is to determine whether the Chinese herbal
supplement, Ningdong granule, is a safe and effective alternative to haloperidol for the treatment
of tic symptoms in pediatric patients with Tourette Syndrome.

METHODS

This systematic review consists of three randomized controlled trials which meet the
specific requirements for measuring efficacy and safety of Ningdong granule (NDG) in addition
or compared to haloperidol or placebo alone. The first randomized control trial was a 3 month,
two group, double-blind study comparing the decrease in tic severity and ADRs of Ningdong
granule plus haloperidol to haloperidol alone. Both NDG/haloperidol and haloperidol were used
at therapeutic doses. The second randomized control trial was an 8-week, three group, doubleblind study that compared the decrease in tic severity and ADRs of NDG to NDG + haloperidol
to haloperidol and placebo alone. The third trial was an 8-week randomized, double blind control
trial comparing NDG to placebo. The study population of all three trials consisted of children or
adolescents at or under the age of 18 and who were clinically diagnosed and met the DSM-IV
criteria for Tourette Syndrome. The populations excluded from these studies were patients over
the age of 18 years old, had comorbid conditions requiring medication, history of recent or
current drug abuse, or had tics that could be accounted for by other medical conditions.

Keywords used in the research for these studies were Tourette and alternative therapy and
Ningdong. All articles used in this research were peer-reviewed journals and were found via
PubMed. The articles were published in English and in Chinese. To be selected, the articles
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researched had to meet several inclusion criteria including: being relevant to the clinical question
proposed, published in 2001 or later, must have been primary research and addressed patient
oriented outcomes (POEM). Criteria for exclusion included articles published prior to the year
2001, articles that were not primary research in nature (other reviews) or if they focused on
disease oriented outcomes (DOE). Statistics used in the articles include p-values, NNT, NNH,
RRI, RBI, and ABI. Table 1 below displays the demographics and characteristics of the studies
that were reviewed and used.

Table 1: Demographics & characteristics of included studies
Study

Type

#Pts

Age Inclusion
(yrs.) Criteria
<18
Pediatric pts
dx with TS

Exclusion
Criteria

W/D Interventions

Li1
(2009)

Double
Blind
RCT

60

- > 18 years
- not matching the
standard of inclusion
- habitual spasm
- complicated with
other ds in an
unstable state
requiring other
medications

0

Haloperidol in
combination with
dosage-form of
NDG, 6 g in each
packet, medicated by
dissolving in boiled
water for oral intake
BID, at the dose of 3
g each time for
children younger
than 6 years, 6 g for
those between 7-11
years and 9 g for
those older than 12
years.

Wang2
(2012)

Double
Blind
RCT

120

6-18

Pediatric pts
dx with TS

3

NDG group assigned
to receive NDG 5
mg/kg/day and one
placebo similar in
appearance and taste
to Haloperidol for 8
weeks.

68

7-18

Pediatric pts
dx with TS

- pts who took TS
medications within 6
mos. of study
- pts who had hx of
seizures, CVD,
organic brain d/o
- current abuse or
dependence on drugs
w/in 6 mos.
- intelligence
quotient (IQ) < 70
per the Wechsler

Zhao3
(2010)

Double
Blind
RCT

4

Subjects received
either an oral dose of
1 g/kg per day (36
g/day max) of NDG
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Intelligence Scale for
Children;19
- tic syndromes
caused by other ds
- dysfunction of the
liver, kidney or other
organs
- a motor or phonic
tic score < 10 on the
Chinese Yale Global
Tic Severity Scale
(YGTSS)

5

powder or placebo
formulated to look
identical to the NDG
to ensure double
blinding the
medication being
administered.

OUTCOMES MEASURED

All studies used measured the desired outcomes of tic severity by diminution rate of Yale
Global Tic Severity Scores (YGTSS) and safety of the drug by way of ADR prevalence.
Participants were given the questionnaires for tic severity prior to the study, immediately after
the study and in the first study, long term results were measured at variable time intervals after
the study. In all studies, safety was measured by recording existence of adverse drug reactions
(ADRs) during treatment in all groups. In the Li study, tic severity was recorded at baseline,
immediately after treatment and then at 6 months for long term efficacy; safety was measured in
ADRs reported and observed vs. control at each interval. In the Wang study, tic severity was
assessed at baseline and every two weeks thereafter until study completion at week 8; safety was
measured by reported and observed ADRs at any time during the study. In the Zhao study, tic
severity was measured at baseline and after 4 and 8 weeks of treatment; safety was measured by
reported and observed ADRs at any time during the study.
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RESULTS

In all three randomly controlled trials, the efficacy and safety of Ningdong granule is
compared to placebo or haloperidol. In the Li study, a total of 60 patients entered the study and
all patients completed the study. The exclusion parameters for this study included patients who
were older than 18, did not match the DSM-IV diagnosis for Tourette Syndrome, had habitual
spasm, or had comorbid disease in an unstable state requiring medication. The patients were all
pediatric patients with tic severity at baseline ranging from mild to severe, including both males
and females in proper proportion. The mean age of patients was 9.59 years.1 Patients were
randomized into two groups by randomizing digital table method where n=30 in the control and
n=60 in the treated group. Ningdong granule used in this study was Shanghai Xinyi Jiufu
Pharmaceutical Co. Ltd., batch No. 061210. Group 2 control was treated with haloperidol alone
at 0.5mg twice per day, titrating to therapeutic doses for each individual. The treated Group 1
was given haloperidol in the same fashion, but supplemented with 3g/dose twice daily for
children 6 years, 6g/dose for ages 7-11 and 9g/dose for 12 years of age. In Group 1 the
clinical efficacy was found to be markedly effective in 36 (60.0%), effective in 21 and
ineffective in 3, with a total effective rate of 95.0%. For the 30 patients in Group 2, data results
were 9 (30.0%), 13, 8, and 73.3%, respectively. Comparing the markedly effective rate and the
total effective rate between the groups showed significant differences (P<0.01, Table 2). For
ADRs in Group 1, drowsiness n=3, lassitude n=2 and poor appetite n=3, the overall ADR rate
was 13.3%, while in Group 2, drowsiness n=4, constipation n=1, lassitude n=3, poor appetite
n=1 and akathisia n=2, with an overall ADR rate of 36.7%. There was statistical significance for
2

ADRs shown (χ =6.54, P<0.05). This study was double blind and there were no limitations to
this study.
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Table 2. Li Study: Comparison YGTSS Score, NDG + Haloperidol vs. Haloperidol
Group
Treated 1
Control 2
2

Case
60
30

Markedly Effective
36 (60.0*)
9 (30.0)
7.20

Effective
21 (35.0)
13 (43.3)
2.63

Ineffective
3 (5.0*)
8 (26.7)
6.85

Total Effective
57 (95.0*)
22 (73.3)
6.85

Note: *P<0.01 when compared with control group
In the Wang study, 120 patients from Provincial Hospital between the ages of 6-18 with
TS were recruited for the study. 3 patients did not submit reports for ADRs, 2 in the placebo
group and 1 in the NDG only group. Exclusion parameters included patients who took TS
medications within 6 months of the study, patients who had history of seizures, cardiovascular
disease, organic brain disorders and those who currently, or within the last 6 months, abused or
were dependent on drugs. The study was done by using a digital random table generator to
randomly assign patients to 4 equal groups (n=30) with Control receiving 2 placebo pills, NDG
receiving Ningdong granule and a placebo, haloperidol receiving haloperidol and placebo and
the Ningdong + haloperidol receiving both drugs. The NDG used was No. 20090412, 999 Co.
Ltd., Shenzhen, China. The mean age of patients was 10.2 years old and there was no significant
difference in weight, age or gender of the groups. Patients in the placebo controlled group had
no significant change in YGTSS total tic score, at each time point when compared to baseline (P
> 0.05). However, two weeks into the study, patients being treated in the three other groups
showed a significant reduction in total YGTSS scores, thus lower tic severity (p < 0.05), with the
NDG + Hal group the most significantly reduced (p < 0.01) (Table 3). While no serious side
effects were reported overall, patients experiencing sedation, extrapyramidal symptoms, QT
prolongation and anxiety for NDG vs. haloperidol were found to be significantly less (p<0.05)
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(Table 4). This study had one limitation for this in that efficacy was assessed over the short
term.

Table 3. Wang Study: Comparison of YGTSS Scores in all Groups

*significance reported at P < 0.05

Table 4. Wang Study: Clinical complications and side effects
ADR
Sedation
Weight gain
EPS
QT Prolongation
Nausea
Headache
Anxiety
Increased Appetite

Control (n=28)
1 (3.5%)
2 (7.0%)
0
0
0
0
1 (3.5%)
0

NDG (n=29
3 (10.3%)*
2 (6.9%)
0*
0*
3 (10.3%)
1 (3.4%)
0*
4 (13.8%)

Hal (n=30)
10 (33.3%)
4 (13.3%)
5 (16.7%)
5 (16.7%)
4 (13.3%)
4 (13.3%)
6 (20.0%)
4 (13.3%)

NDG + Hal (n=30)
12 (40.0%)
5 (16.7%)
5 (16.7%)
5 (16.7%)
4 (13.3%)
6 (20.0%)
4 (13.3%)
7 (23.3%)

Note: * significance P<0.05
The Zhao study evaluated the efficacy and safety of Ningdong granule vs. placebo over
an 8-week randomized, placebo controlled, double blind trial. 68 pediatric patients between the
ages of 7-18 with TS were recruited in this study; 3 patients in the placebo group and 1 in the
NDG group did not complete the full course of treatment and were excluded from analysis.
Exclusion criteria included those who had IQ < 70, tic syndromes caused by other disease,
persons with liver, kidney or any other organ dysfunction, and finally any applicant whose
baseline was <10 on the YGTSS. Patients were randomly assigned to either a treatment group
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(n=33) receiving NDG 1g/kg/day (36 g/day max) or the placebo group (n=31) and given starch
formulated to be identical to NDG at the same frequency. The Ningdong granule used was lot
No. 20051017, manufactured by the Pharmaceutical Department of the Provincial Hospital
Affiliated to Shandong University. There was no significant difference between the groups for
age, weight, gender, previous pharmacotherapy use or baseline YGTSS score (P>0.05). Mean
baseline YGTSS score for Treatment group was 23.00  7.34 and baseline for the placebo group
was 22.42  6.42. YGTSS scores were measured at baseline, 4 and 8 weeks. At each interval
after treatment was started, there was found to be a significant reduction in tic symptoms from
baseline in the NDG treatment group compared to the placebo group, but most notably so at the
end of eight weeks (P<0.001). There was little change in mean total YGTSS score (22.42 6.42
to 20.00  6.12) in the placebo group from baseline to the end of the study. There were no
serious drug reactions reported during the study in either test group, however in the NDG
treatment group there were two patients who experienced a decreased appetite and one who
experienced constipation compared with none in the placebo group. Less than 10% of the
treatment population experienced any type of ADR, which is minimal compared to the
potentially serious side effects of traditional antipsychotics like haloperidol. 2,3 This study had
several limitations in that it was short term, single centered study and was assessed only by the
decrease in YGTSS score.

Table 5. Zhao Study: YGTSS total tic score change for NDG vs. placebo
Group
NDG Treatment
Placebo Control
Statistical significance

Case
33
31

Mean Baseline YGTSS total tic score
23.00  7.34
22.42  6.42
P>0.05

Mean week 8 YGTSS total tic score
13.48  7.25
20.00  6.12
P<0.001
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DISCUSSION

This systematic review assessed the efficacy and safety of the Chinese herbal
supplement, Ningdong granule vs. traditional haloperidol treatment in reducing tic symptoms in
pediatric Tourette syndrome patients. Currently, herbal remedies are not widely used to treat TS
in the United States. The results of these three studies show that NDG is an effective alternative
to haloperidol with a much lower adverse drug reaction profile. While some ADRs for NDG do
exist, they are fewer and far less severe reactions as compared to haloperidol. Drug to drug
interactions were not accounted for in any of the studies as current drug use or medication for
other diseases were criteria for exclusion.

There were several limitations noted with the studies reviewed. First, insurance in the
United States will not currently cover herbal remedies and the FDA does not regulate the
production of herbal supplements. This is a problem for this type of study in the U.S as well as
for consistent production and dosing of the supplement long term. While the Ningdong granules
used were produced by licensed Chinese pharmaceutical companies and were proven to be
consistent in each trial, there was variation in the ingredients used, concentrations of ingredients
and the dose administered between the three studies. Also, powdered human placenta was used
in the formulation of the granule in two studies, which is currently against U.S. FDA regulation.
Second, the results and outcomes were measured in the short term only for two of the three
studies. The Li study also assessed efficacy and ADRs six months after the study but were not
required to answer the question posed in this review. Last, all studies used only one method, the
Yale Global Tic Severity Scale, to assess effectiveness in reducing tics in the patient population.
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CONCLUSION

Ningdong granule is a safe and effective alternative therapy to haloperidol in the relief of
tic symptoms in pediatric aged patients diagnosed with Tourette Syndrome. All three studies
included showed significant evidence improvement in YGTSS scores and thus total tic
symptoms while having significantly fewer adverse drug reactions. Although these studies did
not compare Ningdong to other off-label drugs used for the treatment of tics, NDG has been
shown to be more effective and more safe than the traditional antipsychotics prescribed. Even
with different amounts and small variation in ingredients between manufacturers.

While the Ningdong granules used were produced by licensed Chinese pharmaceutical
companies and were proven to be consistent in each trial, there was variation in the ingredients
used, concentrations of ingredients and the dose administered between the three studies. It would
be beneficial to have a normalized ingredient profile for future studies so that results could be
more easily replicated by future studies. Future studies should be multi-centered comparing
multiple drugs to NDG and assess over the long term while utilizing multiple assessment tools to
measure improvement in tic symptoms and overall psychological well-being. Tools such as
Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOC), Children’s Depression
Inventory (CDI), Clinical Global Impression (CGI-I) and the Multidimensional Anxiety Scale for
Children (MASC) would be beneficial in a multi-centered, long term study.3
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